{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T06:09:55Z","timestamp":1772431795844,"version":"3.50.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016168","name":"King Hussein Cancer Center","doi-asserted-by":"publisher","award":["17 KHCC 37"],"award-info":[{"award-number":["17 KHCC 37"]}],"id":[{"id":"10.13039\/100016168","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Surgery and radiotherapy are the main treatments for localized prostate cancer. Although many retrospective studies have compared their efficacy, evidence from the Middle East and North Africa (MENA) region is limited. This study reports real-world outcomes of patients treated with radical prostatectomy versus definitive radiotherapy at a tertiary cancer center in Jordan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of patients treated between June 2006 and June 2019. Patient demographics, disease characteristics, and treatment details were extracted from electronic medical records. Primary endpoints were cancer-specific survival (CSS) and overall survival (OS); secondary endpoints included metastasis-free survival (MFS) and biochemical relapse-free survival (BRFS). Survival outcomes and group differences were evaluated with the log-rank test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 317 patients, median age was 68 years and median PSA 12.98 ng\/mL. High-risk disease predominated (62.5%), followed by intermediate (32.8%) and low-risk (4.7%). Eighty-nine patients underwent radical prostatectomy and 228 received radiotherapy with androgen deprivation therapy (ADT). Five-year CSS and OS were excellent and similar between surgery and radiotherapy (CSS: 98.7% vs. 96.7%; OS: 90% vs. 89.6%). MFS was comparable (94.9% vs. 94.2%), while BRFS was lower in the surgical group (59.8% vs. 90.5%, p &amp;lt; 0.001). Recurrence occurred in 44.9% of surgical versus 14% of radiotherapy patients, and prostate cancer\u2013specific deaths were 4.4% and 4.3%, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study shows that surgery and radiotherapy achieve excellent long-term survival for localized prostate cancer. Radiotherapy with ADT provides superior biochemical control, emphasizing the importance of individualized, multidisciplinary treatment planning.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1756635","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T05:21:35Z","timestamp":1772428895000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prostatectomy versus definitive radiation for localized prostate cancer: revisiting the debate at a tertiary cancer center"],"prefix":"10.3389","volume":"16","author":[{"given":"Ramiz","family":"Abu-Hijlih","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, King Hussein Cancer Center","place":["Amman, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulla","family":"Alzibdeh","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, King Hussein Cancer Center","place":["Amman, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haneen","family":"Abaza","sequence":"additional","affiliation":[{"name":"Office of Scientific Affairs and Research, King Hussein Cancer Center","place":["Amman, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami","family":"Ghanem","sequence":"additional","affiliation":[{"name":"Department of Surgery, King Hussein Cancer Center","place":["Amman, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdel-Hamid","family":"Khairy","sequence":"additional","affiliation":[{"name":"Department of Surgery, King Hussein Cancer Center","place":["Amman, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaid","family":"Al-Kilani","sequence":"additional","affiliation":[{"name":"Department of Surgery, King Hussein Cancer Center","place":["Amman, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Shahait","sequence":"additional","affiliation":[{"name":"School of Medicine, Al-Sharjah University","place":["Sharjah, United Arab Emirates"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer","family":"Salah","sequence":"additional","affiliation":[{"name":"Adult Oncology Department, King Fahed Specialist Hospital","place":["Dammam, Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fawzi","family":"Abuhijla","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, King Hussein Cancer Center","place":["Amman, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issa","family":"Mohamad","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, King Hussein Cancer Center","place":["Amman, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayat","family":"Taqash","sequence":"additional","affiliation":[{"name":"Office of Scientific Affairs and Research, King Hussein Cancer Center","place":["Amman, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadeel","family":"Abdel Khaleq","sequence":"additional","affiliation":[{"name":"Office of Scientific Affairs and Research, King Hussein Cancer Center","place":["Amman, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikmat","family":"Abdel-Razeq","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Hussein Cancer Center","place":["Amman, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Al-Omari","sequence":"additional","affiliation":[{"name":"Office of Scientific Affairs and Research, King Hussein Cancer Center","place":["Amman, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606220","article-title":"10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14987","article-title":"The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression","volume":"125","author":"Bryant","year":"2020","journal-title":"BJU Int"},{"key":"B4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.eururo.2015.11.010","article-title":"Surgery versus radiotherapy for clinically-localized prostate cancer: A systematic review and meta-analysis","volume":"70","author":"Wallis","year":"2016","journal-title":"Eur Urol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3322\/caac.20066","article-title":"American Cancer Society guideline for the early detection of prostate cancer: update 2010","volume":"60","author":"Wolf","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"B6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/iju.13593","article-title":"Epidemiology of prostate cancer in Asian countries","volume":"25","author":"Kimura","year":"2018","journal-title":"Int J Urol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2015.16.13.5377","article-title":"Predictors of participation in prostate cancer screening among older men in Jordan","volume":"16","author":"Abuadas","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/00469580221095822","article-title":"Early detection of prostate cancer: self-reported knowledge and attitude of physicians in Jordan","volume":"59","author":"Alqudah","year":"2022","journal-title":"Inquiry"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.0050","article-title":"Prostate cancer, version 4.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Schaeffer","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0270956","article-title":"Bone marrow involvement in patients with metastatic castration sensitive prostate cancer","volume":"17","author":"Shahait","year":"2022","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.3332\/ecancer.2023.1646","article-title":"Erratum: Quality and reliability of YouTube videos in Arabic as a source of patient information on prostate cancer","volume":"17","author":"Baqain","year":"2023","journal-title":"Ecancermedicalscience"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4103\/UA.UA_47_20","article-title":"High rates of advanced prostate cancer in the Middle East: Analysis from a tertiary care center","volume":"13","author":"Daher","year":"2021","journal-title":"Urol Ann"},{"key":"B14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.eururo.2016.03.015","article-title":"Impact of prostate-specific antigen (PSA) screening trials and revised PSA screening guidelines on rates of prostate biopsy and postbiopsy complications","volume":"71","author":"Gershman","year":"2017","journal-title":"Eur Urol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003892","article-title":"Salvage Therapy for Prostate Cancer: AUA\/ASTRO\/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy","volume":"211","author":"Morgan","year":"2024","journal-title":"J Urol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/cncr.23139","article-title":"The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer","volume":"112","author":"Abramowitz","year":"2008","journal-title":"Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.3712","article-title":"Prostate-specific antigen-based screening for prostate cancer: evidence report and systematic review for the US preventive services task force","volume":"319","author":"Fenton","year":"2018","journal-title":"Jama"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1200\/GO.24.00237","article-title":"Cancer care in resource-limited countries: Jordan as an example","volume":"10","author":"Abdel-Razeq","year":"2024","journal-title":"JCO Glob Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-020-03221-x","article-title":"Molecular characterization of prostate cancer in Middle Eastern population highlights differences with Western populations with prognostic implication","volume":"146","author":"Abdelsalam","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2014.974827","article-title":"Radical prostatectomy versus high-dose irradiation in localized\/locally advanced prostate cancer: A Swedish multicenter randomized trial with patient-reported outcomes","volume":"54","author":"Lennern\u00e4s","year":"2015","journal-title":"Acta Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2005.05334.x","article-title":"A retrospective study of the treatment of locally advanced prostate cancer by six institutions in eastern and north-eastern Japan","volume":"95","author":"Hachiya","year":"2005","journal-title":"BJU Int"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyl115","article-title":"A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months","volume":"36","author":"Akakura","year":"2006","journal-title":"Jpn J Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.57.7510","article-title":"Final report of the intergroup randomized study of combined androgen-deprivation therapy plus radiotherapy versus androgen-deprivation therapy alone in locally advanced prostate cancer","volume":"33","author":"Mason","year":"2015","journal-title":"J Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/21681805.2018.1520295","article-title":"SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer","volume":"52","author":"Stranne","year":"2018","journal-title":"Scand J Urol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.12.032","article-title":"Surgery versus radiation for high-risk prostate cancer: the fight continues. But is it time to call a draw and reach consensus","volume":"75","author":"Sooriakumaran","year":"2019","journal-title":"Eur Urol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.5_suppl.309","article-title":"Radical prostatectomy (RP) versus radiotherapy (RT) in high-risk prostate cancer (HR-PCa): Emulated randomized comparison with individual patient data (IPD) from two phase III randomized trials (RCTs)","volume":"43","author":"Roy","year":"2025","journal-title":"J Clin Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.62347\/EPGV7486","article-title":"Neoadjuvant chemohormonal therapy before radical prostatectomy in high-risk prostate cancer: a mini-review","volume":"12","author":"Fan","year":"2024","journal-title":"Am J Clin Exp Urol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02158","article-title":"Effect of chemotherapy with docetaxel with androgen suppression and radiotherapy for localized high-risk prostate cancer: the randomized phase III NRG oncology RTOG 0521 trial","volume":"37","author":"Rosenthal","year":"2019","journal-title":"J Clin Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00345-024-05262-0","article-title":"Changing times: trends in risk classification, tumor upstaging, and positive surgical margins after radical prostatectomy - results from a contemporary National Cancer Database study","volume":"42","author":"Freitas","year":"2024","journal-title":"World J Urol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.02.017","article-title":"Positive surgical margins at radical prostatectomy predict prostate cancer","volume":"183","author":"Wright","year":"2010","journal-title":"Specific Mortality J Urol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61095-7","article-title":"Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial","volume":"378","author":"Warde","year":"2011","journal-title":"Lancet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70223-0","article-title":"External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study","volume":"11","author":"Bolla","year":"2010","journal-title":"Lancet Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154499","article-title":"The effectiveness of intensity modulated radiation therapy versus three-dimensional radiation therapy in prostate cancer: A meta-analysis of the literatures","volume":"11","author":"Yu","year":"2016","journal-title":"PLoS One"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1590\/s1677-5538.ibju.2018.0842","article-title":"Intensity modulated radiotherapy (IMRT) or conformational radiotherapy (3D-CRT) with conventional fractionation for prostate cancer: Is there any clinical difference","volume":"45","author":"Viani","year":"2019","journal-title":"Int Braz J Urol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.20156","article-title":"Comparison of acute and chronic surgical complications following robot-assisted, laparoscopic, and traditional open radical prostatectomy among men in Taiwan","volume":"4","author":"Wu","year":"2021","journal-title":"JAMA Netw Open"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1756635\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T05:21:35Z","timestamp":1772428895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1756635\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":35,"alternative-id":["10.3389\/fonc.2026.1756635"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1756635","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"article-number":"1756635"}}